iBio
IBIO
#10128
Rank
C$89.84 M
Marketcap
C$1.81
Share price
-4.04%
Change (1 day)
62.52%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2026 (TTM): C-$1.06

According to iBio's latest financial reports the company's current EPS (TTM) is C-$1.04. In 2025 the company made an earnings per share (EPS) of C-$2.43 an increase over its 2024 EPS that were of C-$9.01.

EPS history for iBio from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$1.06-56.09%
2025C-$2.43-73.08%
2024C-$9.01-93.88%
2023C-$147.16-8.14%
2022C-$160.2092.67%
2021C-$83.15-80.33%
2020C-$422.68-35.11%
2019C-$651.34-38.96%
2018C-$1,067-6.1%
2017C-$1,13636.67%
2016C-$831.5033.33%
2015C-$623.6350%
2014C-$415.75-53.85%
2013C-$900.80-7.14%
2012C-$970.09-64.1%
2011C-$2,70277.27%
2010C-$1,524144.44%
2009C-$623.6312.93%
2008C-$552.2412.2%
2007C-$492.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.10-1,264.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
C-$0.72-30.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
C-$11.67 1,022.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C-$0.24-77.33%๐Ÿ‡บ๐Ÿ‡ธ USA